- Home
- HTBK vs ORGO Comparison
HTBK vs ORGO Comparison
Compare HTBK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTBK | ORGO |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 667.4M | 732.3M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | HTBK | ORGO |
|---|---|---|
| Price | $12.32 | $4.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $12.88 | $8.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.18% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | $187,676,000.00 | ★ $465,218,000.00 |
| Revenue This Year | $13.16 | $8.14 |
| Revenue Next Year | $7.61 | $6.33 |
| P/E Ratio | $17.76 | ★ N/A |
| Revenue Growth | ★ 10.94 | 2.24 |
| 52 Week Low | $8.09 | $2.61 |
| 52 Week High | $12.89 | $7.08 |
Technical Indicators
Market Signals| Indicator | HTBK | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 59.22 | 33.78 |
| Support Level | $11.84 | $4.24 |
| Resistance Level | $12.52 | $5.35 |
| Average True Range (ATR) | 0.30 | 0.28 |
| MACD | -0.07 | -0.14 |
| Stochastic Oscillator | 38.10 | 3.61 |
Price Performance
Historical ComparisonAbout HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.